Product Program year 2020 Source: CMS Open Payments

Flucelvax Quadrivalent (Multi-Dose Vial)

Biological Vaccines

NDC 70461-418-10

Open in the dashboard

General payments

$79,088

1,267 payments

Research payments

$619,096

116 payments

Through program year 2020, $79,088 in general payments and $619,096 in research payments were reported against Flucelvax Quadrivalent (Multi-Dose Vial) (Vaccines).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 General $16,255 303
2020 Research $619,096 116
2019 General $62,833 964

Breakdown

Who paid General payments · program years 2019–2020
  1. Seqirus USA Inc $79,088 1,267 payments
Top recipients General payments · program year 2020
  1. Kathryn Edwards Pediatric Infectious Diseases · Nashville, TN $6,000 37% · 4 payments
  2. Nadim Salomon Infectious Disease · New York, NY $625 4% · 2 payments
  3. Amin Hakim Pediatric Infectious Diseases · Staten Island, NY $625 4% · 2 payments
  4. Candace Johnson Pediatric Infectious Diseases · New York, NY $625 4% · 2 payments
  5. Lisa Saiman Pediatric Infectious Diseases · New York, NY $625 4% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Pediatric Infectious Diseases Pediatrics $8,375 53% · 5 practitioners
  2. Family Medicine $2,433 15% · 112 practitioners
  3. Internal Medicine $2,047 13% · 95 practitioners
  4. Pediatrics $1,013 6% · 25 practitioners
  5. Infectious Disease Internal Medicine $691 4% · 5 practitioners

The top 5 of 22 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Tennessee $6,162 38% · 12 recipients
  2. New York $3,473 21% · 62 recipients
  3. California $2,565 16% · 36 recipients
  4. Pennsylvania $988 6% · 23 recipients
  5. Washington $625 4% · 9 recipients

The top 5 of 27 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,267 general · 116 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record